Sylvain Broussy

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Molecular Docking

Binding Protein

Clinical Practice

Top Venues

Pharmaceuticals (Basel, Switzerland)

Chemistry (Weinheim an der Bergstrasse, Germany)

The Journal of organic chemistry

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Sylvain Broussy
Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Sylvain Broussy
Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Sylvain Broussy
Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Mohadeseh Namjoo, Hossein Ghafouri, Elham Assareh, Amir Reza Aref, Ebrahim Mostafavi, Ali Hamrahi Mohsen, Saeed Balalaie, Sylvain Broussy, S Mohsen Asghari
A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Mohadeseh Namjoo, Hossein Ghafouri, Elham Assareh, Amir Reza Aref, Ebrahim Mostafavi, Ali Hamrahi Mohsen, Saeed Balalaie, Sylvain Broussy, S Mohsen Asghari
A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Xiaoqing Ye, Jean-François Gaucher, Haofeng Hu, Lei Wang, Sylvain Broussy
Dimer Peptide Ligands of Vascular Endothelial Growth Factor: Optimizing Linker Length for High Affinity and Antiangiogenic Activity. Journal of medicinal chemistry (2023)
Jean-François Gaucher, Marie Reille-Seroussi, Sylvain Broussy
Structural and ITC Characterization of Peptide-Protein Binding: Thermodynamic Consequences of Cyclization Constraints, a Case Study on Vascular Endothelial Growth Factor Ligands. Chemistry (Weinheim an der Bergstrasse, Germany) 28 (48) (2022)
Virendra K Tiwari, Douglas R Powell, Sylvain Broussy, David B Berkowitz
Rapid Enantioselective and Diastereoconvergent Hybrid Organic/Biocatalytic Entry into the Oseltamivir Core. The Journal of organic chemistry 86 (9) (2021)
Xiaoqing Ye, Jean-François Gaucher, Michel Vidal, Sylvain Broussy
A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics. Molecules (Basel, Switzerland) 26 (22) (2021)
Afsaneh Sadremomtaz, Ameena M Ali, Foroozan Jouyandeh, Saeed Balalaie, Razieh Navari, Sylvain Broussy, Kamran Mansouri, Matthew R Groves, S Mohsen Asghari
Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application. Signal transduction and targeted therapy 5 (1) (2020)